PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 25.2 EUR 1.61% Market Closed
Market Cap: 302.2m EUR
Have any thoughts about
PharmaSGP Holding SE?
Write Note

Intrinsic Value

The intrinsic value of one PSG stock under the Base Case scenario is 43.29 EUR. Compared to the current market price of 25.2 EUR, PharmaSGP Holding SE is Undervalued by 42%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PSG Intrinsic Value
43.29 EUR
Undervaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
PharmaSGP Holding SE

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PSG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PSG?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about PharmaSGP Holding SE

Provide an overview of the primary business activities
of PharmaSGP Holding SE.

What unique competitive advantages
does PharmaSGP Holding SE hold over its rivals?

What risks and challenges
does PharmaSGP Holding SE face in the near future?

Has there been any significant insider trading activity
in PharmaSGP Holding SE recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PharmaSGP Holding SE.

Provide P/S
for PharmaSGP Holding SE.

Provide P/E
for PharmaSGP Holding SE.

Provide P/OCF
for PharmaSGP Holding SE.

Provide P/FCFE
for PharmaSGP Holding SE.

Provide P/B
for PharmaSGP Holding SE.

Provide EV/S
for PharmaSGP Holding SE.

Provide EV/GP
for PharmaSGP Holding SE.

Provide EV/EBITDA
for PharmaSGP Holding SE.

Provide EV/EBIT
for PharmaSGP Holding SE.

Provide EV/OCF
for PharmaSGP Holding SE.

Provide EV/FCFF
for PharmaSGP Holding SE.

Provide EV/IC
for PharmaSGP Holding SE.

Show me price targets
for PharmaSGP Holding SE made by professional analysts.

What are the Revenue projections
for PharmaSGP Holding SE?

How accurate were the past Revenue estimates
for PharmaSGP Holding SE?

What are the Net Income projections
for PharmaSGP Holding SE?

How accurate were the past Net Income estimates
for PharmaSGP Holding SE?

What are the EPS projections
for PharmaSGP Holding SE?

How accurate were the past EPS estimates
for PharmaSGP Holding SE?

What are the EBIT projections
for PharmaSGP Holding SE?

How accurate were the past EBIT estimates
for PharmaSGP Holding SE?

Compare the revenue forecasts
for PharmaSGP Holding SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PharmaSGP Holding SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PharmaSGP Holding SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of PharmaSGP Holding SE compared to its peers.

Compare the P/E ratios
of PharmaSGP Holding SE against its peers.

Discuss the investment returns and shareholder value creation
comparing PharmaSGP Holding SE with its peers.

Analyze the financial leverage
of PharmaSGP Holding SE compared to its main competitors.

Show all profitability ratios
for PharmaSGP Holding SE.

Provide ROE
for PharmaSGP Holding SE.

Provide ROA
for PharmaSGP Holding SE.

Provide ROIC
for PharmaSGP Holding SE.

Provide ROCE
for PharmaSGP Holding SE.

Provide Gross Margin
for PharmaSGP Holding SE.

Provide Operating Margin
for PharmaSGP Holding SE.

Provide Net Margin
for PharmaSGP Holding SE.

Provide FCF Margin
for PharmaSGP Holding SE.

Show all solvency ratios
for PharmaSGP Holding SE.

Provide D/E Ratio
for PharmaSGP Holding SE.

Provide D/A Ratio
for PharmaSGP Holding SE.

Provide Interest Coverage Ratio
for PharmaSGP Holding SE.

Provide Altman Z-Score Ratio
for PharmaSGP Holding SE.

Provide Quick Ratio
for PharmaSGP Holding SE.

Provide Current Ratio
for PharmaSGP Holding SE.

Provide Cash Ratio
for PharmaSGP Holding SE.

What is the historical Revenue growth
over the last 5 years for PharmaSGP Holding SE?

What is the historical Net Income growth
over the last 5 years for PharmaSGP Holding SE?

What is the current Free Cash Flow
of PharmaSGP Holding SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for PharmaSGP Holding SE.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaSGP Holding SE

Current Assets 69.1m
Cash & Short-Term Investments 40.4m
Receivables 16m
Other Current Assets 12.7m
Non-Current Assets 65.1m
Long-Term Investments 1.8m
PP&E 1m
Intangibles 62.3m
Current Liabilities 38.6m
Accounts Payable 7.2m
Other Current Liabilities 31.5m
Non-Current Liabilities 62.9m
Long-Term Debt 61.8m
Other Non-Current Liabilities 1.1m
Efficiency

Earnings Waterfall
PharmaSGP Holding SE

Revenue
109.8m EUR
Cost of Revenue
-10m EUR
Gross Profit
99.8m EUR
Operating Expenses
-73.7m EUR
Operating Income
26m EUR
Other Expenses
-7.8m EUR
Net Income
18.2m EUR

Free Cash Flow Analysis
PharmaSGP Holding SE

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PSG Profitability Score
Profitability Due Diligence

PharmaSGP Holding SE's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Exceptional 3-Year Average ROIC
68/100
Profitability
Score

PharmaSGP Holding SE's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

PSG Solvency Score
Solvency Due Diligence

PharmaSGP Holding SE's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Average Altman Z-Score
Long-Term Solvency
Positive Net Debt
47/100
Solvency
Score

PharmaSGP Holding SE's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PSG Price Targets Summary
PharmaSGP Holding SE

Wall Street analysts forecast PSG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PSG is 39.53 EUR with a low forecast of 38.38 EUR and a high forecast of 41.48 EUR.

Lowest
Price Target
38.38 EUR
52% Upside
Average
Price Target
39.53 EUR
57% Upside
Highest
Price Target
41.48 EUR
65% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PSG?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PSG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PSG Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

PharmaSGP Holding SE Logo
PharmaSGP Holding SE

Country

Germany

Industry

Pharmaceuticals

Market Cap

302.2m EUR

Dividend Yield

5.4%

Description

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

Contact

BAYERN
Graefelfing
Lochhamer Schlag 21
+49898589639150.0
www.ir.pharmasgp.com

IPO

2020-06-19

Employees

60

Officers

CEO & Member of Management Board
Ms. Natalie Weigand
CFO & Member of Management Board
Mr. Michael Rudolf
Member of Management Board
Peter Gerckens

See Also

Discover More
What is the Intrinsic Value of one PSG stock?

The intrinsic value of one PSG stock under the Base Case scenario is 43.29 EUR.

Is PSG stock undervalued or overvalued?

Compared to the current market price of 25.2 EUR, PharmaSGP Holding SE is Undervalued by 42%.

Back to Top